These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12848409)
1. Factors influencing hepatitis B vaccine uptake in injecting drug users. McGregor J; Marks PJ; Hayward A; Bell Y; Slack RC J Public Health Med; 2003 Jun; 25(2):165-70. PubMed ID: 12848409 [TBL] [Abstract][Full Text] [Related]
2. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Lamagni TL; Davison KL; Hope VD; Luutu JW; Newham JA; Parry JV; Gill ON Commun Dis Public Health; 1999 Sep; 2(3):174-7. PubMed ID: 10491870 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements? Hope VD; Ncube F; Hickman M; Judd A; Parry JV J Viral Hepat; 2007 Sep; 14(9):653-60. PubMed ID: 17697018 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. Lamden KH; Kennedy N; Beeching NJ; Lowe D; Morrison CL; Mallinson H; Mutton KJ; Syed Q J Infect; 1998 Nov; 37(3):260-9. PubMed ID: 9892530 [TBL] [Abstract][Full Text] [Related]
5. Adherence to hepatitis B virus vaccination at syringe exchange sites. Altice FL; Bruce RD; Walton MR; Buitrago MI J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. Lum PJ; Ochoa KC; Hahn JA; Page Shafer K; Evans JL; Moss AR; Am J Public Health; 2003 Jun; 93(6):919-23. PubMed ID: 12773355 [No Abstract] [Full Text] [Related]
7. A comparison of the determinants of safe injecting and condom use among injecting drug users. Myers T; Millson M; Rigby J; Ennis M; Rankin J; Mindell W; Strathdee S Addiction; 1995 Feb; 90(2):217-26. PubMed ID: 7703815 [TBL] [Abstract][Full Text] [Related]
8. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK? Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574 [TBL] [Abstract][Full Text] [Related]
9. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Rhodes T; Mikhailova L; Sarang A; Lowndes CM; Rylkov A; Khutorskoy M; Renton A Soc Sci Med; 2003 Jul; 57(1):39-54. PubMed ID: 12753815 [TBL] [Abstract][Full Text] [Related]
10. [Risk factors for hepatitis C among injecting drug users in Oslo]. Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801 [TBL] [Abstract][Full Text] [Related]
11. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Cook PA; McVeigh J; Syed Q; Mutton K; Bellis MA Addiction; 2001 Dec; 96(12):1787-97. PubMed ID: 11784471 [TBL] [Abstract][Full Text] [Related]
12. Operating needle exchange programmes in the hills of Thailand. Gray J AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363 [TBL] [Abstract][Full Text] [Related]
13. Injecting drug use in prison: prevalence and implications for needle exchange policy. Wright NM; Tompkins CN; Farragher TM Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704 [TBL] [Abstract][Full Text] [Related]
14. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy. Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccine uptake among injecting drug users. Lawson J; Holtby I; Eynon C J Public Health (Oxf); 2004 Mar; 26(1):116-7. PubMed ID: 15044587 [No Abstract] [Full Text] [Related]
16. Increasing hepatitis B vaccine coverage in prisons in England and Wales. Gilbert RL; Costella A; Piper M; Gill ON Commun Dis Public Health; 2004 Dec; 7(4):306-11. PubMed ID: 15779795 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055 [TBL] [Abstract][Full Text] [Related]
18. Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. Wright NM; Tompkins CN; Jones L Health Soc Care Community; 2005 Jan; 13(1):75-83. PubMed ID: 15717909 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users. Robinson GM; Reynolds JN; Robinson BJ N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873 [TBL] [Abstract][Full Text] [Related]
20. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program. Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]